GlassScriptPhysician profile
Revati Reddy
NPI 1790147213
$7,302.33
in general payments reported to CMS, 2019-2025
20 companies · $3,954 in 2025
The $3,954 reported for 2025 was more than what 97% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $846 · 2023: $986 · 2024: $1,516 · 2025: $3,954.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,808 · Travel and Lodging: $2,515 · Education: $134.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,808.09 |
| Travel and Lodging | $2,514.62 |
| Education | $133.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,314.69 | 2022-2025 | Gallant, Cardiomems, Optis |
| Abiomed | $1,509.54 | 2022-2025 | Impella |
| Novartis Pharmaceuticals Corporation | $647.42 | 2023-2025 | |
| Shockwave Medical, INC | $289.40 | 2025 | |
| Medtronic, INC. | $243.44 | 2023-2025 | Onyx Frontier, Micra |
| Amgen INC. | $187.07 | 2024-2025 | Repatha, Repatha |
| Penumbra, INC. | $143.00 | 2025 | Indigo System |
| Boston Scientific Corporation | $142.20 | 2025 | General - Vascular Access, Stingray, Avvigo Guidance System |
| Chiesi USA, INC. | $135.25 | 2022-2025 | Kengreal, Cleviprex |
| Bayer Healthcare Pharmaceuticals INC. | $121.19 | 2022 | |
| Janssen Pharmaceuticals, INC | $119.97 | 2024 | Xarelto |
| Novo Nordisk INC | $99.81 | 2025 | Ozempic |
| E.R. Squibb & Sons, L.L.C. | $98.27 | 2023 | Camzyos |
| Cvrx, INC. | $66.32 | 2023 | Barostim Neo System |
| W. L. Gore & Associates, INC. | $50.00 | 2025 | Gore-Tex Vascular Graft |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $40.06 | 2023 | Lifesparc |
| Irhythm Technologies, INC. | $31.14 | 2024 | Zio At Patch |
| Terumo Medical Corporation | $27.96 | 2025 | Metacross Otw, Angio-Seal, Tr Band |
| Pfizer INC. | $18.76 | 2024 | |
| Bridgebio Pharma, INC. | $16.84 | 2025 | Attruby |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Revati Reddy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.